As artificial intelligence (AI) promises to remake drug discovery, recent clinical trial results reveal its potential and challenges. Recursion Pharmaceuticals, a self-described “clinical stage TechBio...
When aiming to create value through mergers and acquisitions (M&A), acquirers must select the best in breed among potential acquisitions and then honor both the...